Cofnodi Dyfyniadau

Citação APA (7ª ed.)
Sattayalertyanyong, O., Bandidniyamanon, W., Limsrivilai, J., Chotiyaputta, W., Nimanong, S., & Tanwandee, T. (2026). Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. Nature Portfolio.
Citação do estilo Chicago (17ª ed.)
Sattayalertyanyong, Onuma, Wimolrak Bandidniyamanon, Julajak Limsrivilai, Watcharasak Chotiyaputta, Supot Nimanong, e Tawesak Tanwandee. Long-term HBsAg Clearance, Relapse, and Safety Following Tenofovir or Entecavir Discontinuation in Non-cirrhotic, HBeAg-negative Chronic Hepatitis. Nature Portfolio, 2026.
Citação MLA (9ª ed.)
Sattayalertyanyong, Onuma, et al. Long-term HBsAg Clearance, Relapse, and Safety Following Tenofovir or Entecavir Discontinuation in Non-cirrhotic, HBeAg-negative Chronic Hepatitis. Nature Portfolio, 2026.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.